MIBG Avidity and Progression-Free Survival in Patients With Metastatic Pheochromocytoma Are Not Dependent on Germline SDHx Mutation Status

Fishbein Lauren; Bennett Bonita; Narayan Vivek; Nathanson Katherine L.; Cengel Keith; Cohen Debbie L.; Pryma Daniel A.

首页> 外文期刊>Pancreas >MIBG Avidity and Progression-Free Survival in Patients With Metastatic Pheochromocytoma Are Not Dependent on Germline SDHx Mutation Status

【24h】

MIBG Avidity and Progression-Free Survival in Patients With Metastatic Pheochromocytoma Are Not Dependent on Germline SDHx Mutation Status

机译：转移性嗜铬细胞瘤患者的MIBG亲密和无进展生存率不依赖于种系SDHX突变状态

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pancreas 》 |2018年第3期| 共2页
作者
Fishbein Lauren; Bennett Bonita; Narayan Vivek; Nathanson Katherine L.; Cengel Keith; Cohen Debbie L.; Pryma Daniel A.;
展开▼
作者单位

Univ Colorado Sch Med Denver CO USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

Univ Penn Perelman Sch Med Philadelphia PA 19104 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词

相似文献

外文文献
中文文献
专利

1. MIBG Avidity and Progression-Free Survival in Patients With Metastatic Pheochromocytoma Are Not Dependent on Germline SDHx Mutation Status [J] . Fishbein Lauren, Bennett Bonita, Narayan Vivek, Pancreas . 2018 ,第3期

机译：转移性嗜铬细胞瘤患者的MIBG亲密和无进展生存率不依赖于种系SDHX突变状态
2. Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis [J] . Journal of Medical Genetics . 2020 ,第4期

机译：SDHX突变载体中转移性嗜铬细胞瘤和Paraganglioma的风险：系统审查和更新的荟萃分析
3. Prevalence and spectrum of SDHx mutations in pheochromocytoma and paraganglioma in patients from Belgium: An update [J] . PersuA., LannoyN., MaiterD., Hormone and Metabolic Research . 2012 ,第5期

机译：比利时患者嗜铬细胞瘤和副神经节瘤中SDHx突变的患病率和光谱：最新情况
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Association of patient-reported outcomes with progression-free survival in malignant pleural mesothelioma. [D] . Hackshaw, Michelle Denise. 2010

机译：患者报告的结局与恶性胸膜间皮瘤无进展生存的相关性。
6. OR25-07 A Multi-Center Open-Label Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma: Updated Long-Term Survival and Safety [O] . Camilo Jimenez, Bennett B Chin, Richard B Noto, 2020

机译：OR25-07一个多中心开放标签枢轴相2研究Azedra®（HSA I-131-MIBG）在不可切除的局部晚期或转移性嗜铬细胞瘤或伞菌脑瘤或伞形脑膜瘤的患者中的研究：更新的长期存活和安全性
7. OR25-07 A Multi-Center, Open-Label, Pivotal Phase 2 Study of Azedra® (HSA I-131-MIBG) in Patients with Unresectable, Locally Advanced or Metastatic Pheochromocytoma or Paraganglioma: Updated Long-Term Survival and Safety [O] . Camilo Jimenez, Bennett B Chin, Richard B Noto, 2020

机译：OR25-07一个多中心，开放标签，枢轴相2研究Azedra®（HSA I-131-MIBG）在不可切除的，局部晚期或转移性嗜铬细胞瘤或伞菌脑瘤或伞形脑膜瘤的患者中的研究：更新的长期存活和安全性

MIBG Avidity and Progression-Free Survival in Patients With Metastatic Pheochromocytoma Are Not Dependent on Germline SDHx Mutation Status

著录项

相似文献

相关主题

期刊订阅